Tak Cuma Nakes, Sopir Oksigen di Karanganyar Pun Tumbang Kewalahan Hadapi Tingginya Kasus Covid-19
Tak Cuma Nakes, Sopir Oksigen di Karanganyar Pun Tumbang Kewalahan Hadapi Tingginya Kasus Covid-19
Empat dari lima sopir PT Samator Gas Industri Surakarta yang mendistribusikan oksigen tumbang karena kewalahan. Tim Satgas Covid-19 Karanganyar siap membantu.
SOLOPOS.COM - Dandim 0727/Karanganyar Letkol (Inf) Ikhsan Agung Widyo Wibowo bersama Kapolres Karanganyar AKBP Muchammad Syafi Maulla mengecek stok, pasokan, dan distribusi oksigen di PT Samator Gas Industri Surakarta, Senin (5/7/2021). (Istimewa/Sub Bagian Humas Polres Karanganyar)
Solopos.com, KARANGANYAR Tak hanya tenaga kesehatan (nakes) yang kewalahan menghadapi tingginya lonjakan kasus Covid-19. Hal yang sama dialami para sopir pengangkut tabung oksigen yang harus bekerja ekstra keras karena meningkatnya kebutuhan.
Kapolres-Dandim Datangi Perusahaan Pemasok Oksigen Di Karanganyar, Ternyata Begini Kondisinya
solopos.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from solopos.com Daily Mail and Mail on Sunday newspapers.
Pecah Kerumunan, TNI AU Bagikan Vaksin Covid-19 ke 2 Puskesmas Colomadu Karanganyar
solopos.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from solopos.com Daily Mail and Mail on Sunday newspapers.
AS Bagikan Vaksin Corona ke Dunia, Apa Tujuannya?
solopos.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from solopos.com Daily Mail and Mail on Sunday newspapers.
Waiving vaccine patents will not result in swifter availability in less developed nations. Developing countries obviously need Covid-19 diagnostics, therapeutics and vaccines as quickly as possible. But removing intellectual property protections could in fact slow that down.
In the past, when developing countries have issued “compulsory licenses” which effectively allow domestic manufacturers to create knockoff treatments even before drug patents expire it has taken years for generic manufacturers to receive the drug formulas and scale up production. Such extreme measures simply aren’t necessary.
The companies that created lifesaving Covid-19 vaccines and therapies have already promised to share them widely in the developing world. Waiving patents wouldn’t speed the rollout of existing vaccines, but it would ensure we’re less prepared to fight the next pandemic, setting a terrible precedent that will chill future medical innovation.